Xencor | Salg



Sales Endring Dato
AbbVie USD 15.1B 642M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Biogen USD 2.45B 11.1M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
J&J USD 22.52B 49M 2024-12
MacroGenics USD 110.71M 99.91M 2024-09
Merck USD 15.62B 1.03B 2024-12
Novartis USD 13.15B 330M 2024-12
Pfizer USD 17.76B 61M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Xencor USD 70.02M 59.31M 2024-12



Xencor Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.